NYSE$ZEPP

ZEPP Health Corp.-ADR · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Headline financials

Total Revenue

$302M

Previous: $303M-0.3%
EPS (adj)

$1.20

Previous: $0.46+160.9%
Capital Expenditures

$83.6M

Previous: $34.3M+143.8%
Free Cash Flow

$73.7M

Previous: $394M-81.3%
Net Income

$115M

Previous: $207M-44.4%
Operating Income

$63.7M

Previous: $218M-70.7%
Gross Profit

$375M

Previous: $503M-25.5%
Cash & Equivalents

$348M

Previous: $259M+34.5%
Total Assets

$905M

Previous: $743M+21.7%
Stock-Based Comp

$65.2M

Previous: $55.1M+18.2%

Revenue & EPS history

ZEPP Health · Revenue · Quarterly

$302M

Q4 2020-0.3%vs Q4 2019
Beat estimate in 4 of 15 quarters(27%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q4 2020

Historical avgQ4 2020

-2.3%

Avg return

Earnings day

-3.4%

Avg return

5 days after

+1.6%

Avg return

30 days after

24%

9 / 37 earnings

Positive

+32.6%

Q2 2025

Best reaction

-29.3%

Q1 2027

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2027-29.3%-24.1%
Q1 2026+0.0%-1.4%-44.9%
Q4 2026-12.1%-17.3%-13.5%
Q3 2025-6.1%-39.6%-22.9%
Q2 2025+32.6%+91.2%+312.8%
Q1 2025-5.1%-10.2%-15.8%
Q4 2024+15.3%+2.7%-9.7%
Q3 2024-14.9%-19.7%-8.7%
Q2 2024+19.7%-3.3%+10.0%
Q1 2024-6.2%-13.5%-22.5%
Q4 2023-8.5%-17.0%-29.4%
Q3 2023+9.8%-5.7%+12.2%
Q2 2023-4.2%-5.8%-6.7%
Q1 2023-11.2%-14.9%-16.4%
Q4 2022-6.9%-11.5%-11.5%
Q3 2022-4.5%-7.0%+21.0%
Q2 2022-9.1%-7.2%-28.8%
Q1 2022-8.2%-6.8%-9.5%
Q4 2021-0.6%-1.3%-15.1%
Q3 2021-5.8%-9.3%-46.4%
Q2 2021-1.0%+10.7%-5.6%
Q1 2021-3.4%+3.9%+13.8%
Q4 2020-2.1%-10.2%-28.6%
Q3 2020-11.3%-16.4%-18.4%
Q2 2020-11.1%-8.8%-4.2%
Q1 2020-16.7%-19.9%-19.7%
Q4 2019-5.2%+1.7%-2.8%
Q3 2019+5.0%+13.9%+10.1%
Q2 2019-1.5%-14.0%-5.7%
Q1 2019+8.7%+18.3%+35.3%
Q4 2018-7.9%-13.9%-18.1%
Q3 2018-6.8%+7.6%-1.8%
Q2 2018+9.1%+4.7%+0.4%
Q1 2018+18.8%+21.8%+20.5%
Q4 2015-1.5%-0.9%+21.6%
Q4 2016-1.5%-0.9%+21.6%
Q4 2017+0.1%-0.5%-15.3%
Q3 2017
Q2 2017
Q1 2017

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro